Trials / Completed
CompletedNCT06122961
Levels of Inflammation in People With Cardiovascular Disease (POSEIDON)
Prevalence of Systemic Inflammation in Patients With Atherosclerotic Cardiovascular Disease and Heart Failure
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 18,198 (actual)
- Sponsor
- Novo Nordisk A/S · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will collect medical and background information from participants with diseases that affect the heart and blood vessels (cardiovascular disease). Participants will continue their normal care and will not get any treatment other than those the study doctor has prescribed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No treatment given | No treatment given |
Timeline
- Start date
- 2023-11-23
- Primary completion
- 2025-04-30
- Completion
- 2025-04-30
- First posted
- 2023-11-08
- Last updated
- 2025-05-09
Locations
195 sites across 17 countries: United States, Argentina, Australia, Brazil, Canada, China, Czechia, Denmark, France, Germany, India, Italy, Norway, Poland, South Korea, Sweden, United Kingdom
Source: ClinicalTrials.gov record NCT06122961. Inclusion in this directory is not an endorsement.